It was found that the observed decrease in the contents of both GGA1 and GGA3 in AD correlates with the increase in BACE1 and the increased postprocessing proteolysis of the protein APP through the amyloidogenic pathway. The gene discussed is BACE1; the disease is Alzheimer disease.